| ACE-I | angiotensin-converting enzyme inhibitor |
| ACE | angiotensin-converting enzyme |
| ARB | angiotensin II receptor blocker |
| ASA | acetylsalicylic acid |
| BMI | body mass index |
| CAD | coronary artery disease |
| CABG | coronary artery bypass grafting |
| CD163 | cluster of differentiation 163 |
| CXCL4 | C-X-C motif chemokine ligand 4 |
| DASH | Dietary Approaches to Stop Hypertension |
| DISCO-CT | Dietary Intervention to Stop Coronary Atherosclerosis in Computed Tomography |
| ELISA | enzyme-linked immunosorbent assay |
| ESC | European Society of Cardiology |
| FFQ | food frequency questionnaire |
| HDL-C | high-density lipoprotein cholesterol |
| hs-CRP | high-sensitivity C-reactive protein |
| IBM SPSS | International Business Machines Statistical Package for the Social Sciences |
| IL-6 | interleukin-6 |
| LDL-C | low-density lipoprotein cholesterol |
| MACE | major adverse cardiovascular events |
| MCP-1 | monocyte chemoattractant protein-1 |
| MI | myocardial infarction |
| NHANES | National Health and Nutrition Examination Survey |
| non-HDL-C | non-high-density lipoprotein cholesterol |
| PCI | percutaneous coronary intervention |
| RANTES | Regulated on Activation, Normal T Cells Expressed and Secreted |
| SAFA | saturated fatty acids |
| SMM | skeletal muscle mass |
| TBF | total body fat |
| TNF-α | tumour necrosis factor-alpha |
| VFA | visceral fat area |